New to SCOPE 2024 - we bring together for the first time, a business-focused panel of strategics from the pharma, investor, healthcare, CRO, and technology start-up communities, to discuss partnership models that drive much needed innovation in clinical trials and impact development at the portfolio level. In this panel we will address the following questions:

• How can Pharma manage risks and investments while continuing to remain at the forefront of drug development, clinical research, and trial technology?
• What alternative business models and risk-sharing partnership can support innovation, in a resource constrained environment?
• Where are the opportunities and the ROI from such partnerships?
• What emerging technologies are showing growth and investment and are moving the needle in clinical research?

Join us as Colin Weller, GM, Evidence Generation Platform at Medable, unveils how intelligent automation technology reduces clinical trial deployment timelines and accelerates evidence generation at scale as shown in their latest results to reduce trial deployment timelines by 50%. Weller will discuss how Top-10 global pharmaceutical companies are benefiting from Medable’s novel technology, and how the expanded use of digital measures and biomarkers will continue to accelerate clinical development timelines.